Imkeldi is a Antineoplastic - BCR-ABL Kinase Inhibitors class drug made by SHORLA ONCOLOGY. The typical out-of-pocket price for Imkeldi is $4,709.57 per 140, 80mg/ml solution (quantity in ml), but you can pay $2,369.25 for 140, 80mg/ml solution (quantity in ml)s of Imkeldi with your SingleCare discount card.
This is a limited availability drug and is not available at most pharmacies
We recommend contacting your insurance company about the availability of this drug.
About Imkeldi
Imkeldi is a Antineoplastic - BCR-ABL Kinase Inhibitors class drug made by SHORLA ONCOLOGY. The typical out-of-pocket price for Imkeldi is $4,709.57 per 140, 80mg/ml solution (quantity in ml), but you can pay $2,369.25 for 140, 80mg/ml solution (quantity in ml)s of Imkeldi with your SingleCare discount card.
About Imkeldi
Imkeldi is a Antineoplastic - BCR-ABL Kinase Inhibitors class drug made by SHORLA ONCOLOGY. The typical out-of-pocket price for Imkeldi is $4,709.57 per 140, 80mg/ml solution (quantity in ml), but you can pay $2,369.25 for 140, 80mg/ml solution (quantity in ml)s of Imkeldi with your SingleCare discount card.
Subscribe to our savings newsletter
Health education, drug info, wellness & more
By clicking 'Subscribe', I agree to SingleCare's Terms & Conditions.
